What is the half-life of Relugolix?

The mean effective half-life of Relugolix is 25 hours, and the mean terminal elimination half-life is 60.8 hours. Repagolicis the first (and currently the only) oral GnRHreceptor antagonist approved for the treatment of prostate cancer. The protein binding rate of Repagliflozin in plasma is 68-71%, and it is mainly bound to albumin and secondarily to α1-acidic glycoprotein. Regaglic is mainly metabolized by the CYP3A subfamily of P450 enzymes, with CYP2C8 playing a smaller role. Approximately 81% of the oral dose was recovered in feces, of which 4.2% was unchanged parent drug, and 4.1% of the dose was recovered in urine, of which 2.2% remained unchanged. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.